• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Science & Research

  • Print
  • Share
  • E-mail

Critical Path Initiative

Four images: Woman looking through microscope, Gloved hands holding test tube, Pills coming down a manufacturing shoot., Doctor holding a baby

Transforming the way FDA-regulated products are developed, evaluated, and manufactured


Highlights

 


About Critical Path


The Critical Path Initiative (CPI) is FDA's national strategy for transforming the way FDA-regulated medical products are developed, evaluated, and manufactured.  ... More

  

 

Contact FDA

Office of Regulatory Science and Innovation

Carol D. Linden, PhD

Director

301-796-8527

-